Authors:
DAHLOF C
HOGENHUIS L
OLESEN J
PETIT H
RIBBAT J
SCHOENEN J
BOSWELL D
FUSEAU E
HASSANI H
WINTER P
Citation: C. Dahlof et al., EARLY CLINICAL-EXPERIENCE WITH SUBCUTANEOUS NARATRIPTAN IN THE ACUTE TREATMENT OF MIGRAINE - A DOSE-RANGING STUDY, European journal of neurology, 5(5), 1998, pp. 469-477
Citation: C. Duquesnoy et al., COMPARATIVE CLINICAL PHARMACOKINETICS OF SINGLE DOSES OF SUMATRIPTAN FOLLOWING SUBCUTANEOUS, ORAL, RECTAL AND INTRANASAL ADMINISTRATION, European journal of pharmaceutical sciences, 6(2), 1998, pp. 99-104
Authors:
FUSEAU E
WEBSTER C
ASGHARNEJAD M
HUFFMAN C
SAMBOL N
LIU CY
Citation: E. Fuseau et al., ACUTE TREATMENT OF MIGRAINE WITH ORAL NARATRIPTAN - THE CONCENTRATION-EFFICACY RELATIONSHIP, Clinical pharmacology and therapeutics, 63(2), 1998, pp. 58-58
Authors:
MOORE KHP
HUSSEY EK
SHAW S
FUSEAU E
DUQUESNOY C
PAKES GE
Citation: Khp. Moore et al., SAFETY, TOLERABILITY, AND PHARMACOKINETICS OF SUMATRIPTAN IN HEALTHY-SUBJECTS FOLLOWING ASCENDING SINGLE INTRANASAL DOSES AND MULTIPLE INTRANASAL DOSES, Cephalalgia, 17(4), 1997, pp. 541-550
Authors:
COSSON VF
FUSEAU E
EFTHYMIOPOULOS C
BYE A
Citation: Vf. Cosson et al., MIXED EFFECT MODELING OF SUMATRIPTAN PHARMACOKINETICS DURING DRUG DEVELOPMENT .1. INTERSPECIES ALLOMETRIC SCALING, Journal of pharmacokinetics and biopharmaceutics, 25(2), 1997, pp. 149-167
Authors:
CHOSIDOW O
DUBRUC C
DANJOU P
FUSEAU E
ESPAGNE E
BIANCHETTI G
THENOT JP
HERSON S
ROSENZWEIG P
REVUZ J
Citation: O. Chosidow et al., PLASMA AND SKIN SUCTION-BLISTER-FLUID PHARMACOKINETICS AND TIME-COURSE OF THE EFFECTS OF ORAL MIZOLASTINE, European Journal of Clinical Pharmacology, 50(4), 1996, pp. 327-333
Authors:
BERLIN I
ROSENZWEIG P
CHALON S
FUSEAU E
LANDAULT C
CESSELIN F
BLACKER C
PUECH AJ
Citation: I. Berlin et al., REDUCTION OF HYPERGLYCEMIA AFTER ORAL GLUCOSE-LOAD BY THE NEW ALPHA(2)-ADRENERGIC RECEPTOR ANTAGONIST SL84.0418 IN HEALTHY-SUBJECTS, Clinical pharmacology and therapeutics, 55(3), 1994, pp. 338-345